US 7067661
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted A61PA61P1/04A61P1/16
Quick answer
US patent 7067661 (Pyrazolopyrimidines as cyclin dependent kinase inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P11/02, A61P13/08